Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1992-9-17
|
pubmed:abstractText |
The association between clinical autonomic dysfunction and myocardial MIBG accumulation was investigated. The study groups comprised 6 male diabetic patients with autonomic neuropathy (ANP+ group), 6 male diabetic patients without autonomic neuropathy (ANP-group), and 6 male nondiabetic control subjects. The mean age was comparable in all groups, and the subjects had no evidence of coronary heart disease. Reduced heart-rate variation in a deep-breathing test was used as a criterion for autonomic neuropathy. Immediately after injection, the peak net influx rate of MIBG to myocardium was significantly (P less than 0.05) reduced in both diabetic groups. At 6 hr after MIBG injection, the MIBG uptake of the myocardium was significantly (P less than 0.05) smaller in the ANP+ group than in the control group. In the ANP- group, the MIBG uptake of the myocardium was between that of the ANP+ group and that of the control group. Our data show that reduced myocardial MIBG accumulation is associated with autonomic dysfunction in diabetic patients, but it can occur to a lesser extent also in diabetic patients without apparent autonomic neuropathy. The measurement of the myocardial MIBG accumulation is a promising new method to detect cardiac sympathetic nervous dysfunction in diabetic patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-Iodobenzylguanidine,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Iodobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Sympatholytics
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1069-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1499860-3-Iodobenzylguanidine,
pubmed-meshheading:1499860-Autonomic Nervous System,
pubmed-meshheading:1499860-Catecholamines,
pubmed-meshheading:1499860-Diabetes Mellitus,
pubmed-meshheading:1499860-Diabetic Neuropathies,
pubmed-meshheading:1499860-Heart Rate,
pubmed-meshheading:1499860-Humans,
pubmed-meshheading:1499860-Injections, Intravenous,
pubmed-meshheading:1499860-Iodine Radioisotopes,
pubmed-meshheading:1499860-Iodobenzenes,
pubmed-meshheading:1499860-Isometric Contraction,
pubmed-meshheading:1499860-Male,
pubmed-meshheading:1499860-Middle Aged,
pubmed-meshheading:1499860-Myocardium,
pubmed-meshheading:1499860-Sympathetic Nervous System,
pubmed-meshheading:1499860-Sympatholytics
|
pubmed:year |
1992
|
pubmed:articleTitle |
Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine.
|
pubmed:affiliation |
Department of Clinical Physiology, Kuopio University Hospital, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|